| Genetic Ablation of CD33 in HSC to Broaden the Therapeutic Index of CD33-directed Immunotherapy in Patients with AML (NCT05662904) | German Cancer Research Center | 2028-01-01 |
| Treatment Guided by Comprehensive Genome and Transcriptome Analysis Versus Standard of Care in Advanced Rare Cancers (NCT06855134) | German Cancer Research Center | 2025-09-29 |
| Cancer Literacy as an Essential Factor for Lifestyle Behavior Changes: An Observational and Interventional Study (NCT06614673) | German Cancer Research Center | 2025-01-30 |
| Natural Killer Cell Immunotherapy in Combination With PARP-inhibition in Acute Myeloid Leukemia (NCT05319249) | German Cancer Research Center | 2024-06-01 |
| Perioperative Platelet Inhibition With Acetylsalicylic Acid in Patients With Resectable Tumors of the Pancreatic Head (NCT05637567) | German Cancer Research Center | 2024-04-01 |
| Evaluation of Text or Animation-based Narrative and Non-narrative Interventions to Enhance Cancer Literacy: a Pilot Study (CLARO) (NCT06026384) | German Cancer Research Center | 2024-02-27 |
| FIH, Bispecific CD276xCD3 Antibody CC-3 in Patients With Colorectal Cancer (NCT05999396) | German Cancer Research Center | 2024-01-12 |
| Genomics Guided Targeted Post-neoadjuvant Therapy in Patients With Early Breast Cancer (COGNITION-GUIDE) (NCT05332561) | German Cancer Research Center | 2023-06-29 |
| A MultIceNTER Phase I Peptide VaCcine Trial for the Treatment of H3-Mutated Gliomas (NCT04808245) | German Cancer Research Center | 2023-02-15 |
| A Trial of Cobicistat and Gemcitabine and Nab-Paclitaxel in Patients with Advanced Stage or Metastatic Pancreatic Ductal Adenocarcinoma (NCT05494866) | German Cancer Research Center | 2022-12-07 |
| Artificial Intelligence Based Melanoma Early Diagnosis and Risk Prediction in Children, Adolescents and Young Adults (NCT06621810) | German Cancer Research Center | 2022-12-01 |
| PANHPVAX, Study of a New HPV Vaccine in Healthy Volunteers (NCT05208710) | German Cancer Research Center | 2022-11-07 |
| Afatinib in Advanced NRG1-Rearranged Malignancies (NCT04410653) | German Cancer Research Center | 2022-07-31 |
| Bispecific PSMAxCD3 Antibody CC-1 in Patients With Squamous Cell Carcinoma of the Lung (NCT04496674) | German Cancer Research Center | 2022-02-02 |
| CRAFT: The NCT-PMO-1602 Phase II Trial (NCT04551521) | German Cancer Research Center | 2021-10-13 |
| Longitudinal Investigation of Cancer-related Fatigue and Its Treatment (LIFT Project) (NCT04921644) | German Cancer Research Center | 2021-08-04 |
| Testing for COVID-19 Infection in Asymptomatic Persons (NCT04345510) | German Cancer Research Center | 2020-04-20 |
| COGNITION: Genomics-Guided Precision Oncology in Early High-Risk Breast Cancer (NCT05906407) | German Cancer Research Center | 2019-04-19 |
| Longitudinal Investigation of Cancer-related Fatigue (NCT03211273) | German Cancer Research Center | 2019-03-01 |
| Molecularly Aided Stratification for Tumor Eradication Research (NCT05852522) | German Cancer Research Center | 2018-11-11 |
| AMPLIFYing NEOepitope-specific VACcine Responses in Progressive Diffuse Glioma (NCT03893903) | German Cancer Research Center | 2018-10-19 |
| Systematic and Mechanism-based Approach to Rational Treatment Trials of Blood Cancer (NCT03488641) | German Cancer Research Center | 2018-04-16 |
| Fatigue Prevalence, Severity, and State of Treatment in Germany (NCT03318224) | German Cancer Research Center | 2017-11-30 |